181 related articles for article (PubMed ID: 11994285)
1. Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4 alpha.
Bartoov-Shifman R; Hertz R; Wang H; Wollheim CB; Bar-Tana J; Walker MD
J Biol Chem; 2002 Jul; 277(29):25914-9. PubMed ID: 11994285
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of the Atlantic salmon hepatocyte nuclear factor (HNF) 1 promoter by the orphan nuclear receptors HNF4 and chicken ovalbumin upstream promoter transcription factor I (COUP-TFI).
McNair A; Cereghini S; Brand H; Smith T; Breillat C; Gannon F
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):557-64. PubMed ID: 11085951
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer.
Ceelie H; Spaargaren-Van Riel CC; De Jong M; Bertina RM; Vos HL
J Thromb Haemost; 2003 Aug; 1(8):1688-98. PubMed ID: 12911579
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha.
Rajas F; Gautier A; Bady I; Montano S; Mithieux G
J Biol Chem; 2002 May; 277(18):15736-44. PubMed ID: 11864989
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.
Jung D; Kullak-Ublick GA
Hepatology; 2003 Mar; 37(3):622-31. PubMed ID: 12601360
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte nuclear factor 4 alpha isoforms originated from the P1 promoter are expressed in human pancreatic beta-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms.
Eeckhoute J; Moerman E; Bouckenooghe T; Lukoviak B; Pattou F; Formstecher P; Kerr-Conte J; Vandewalle B; Laine B
Endocrinology; 2003 May; 144(5):1686-94. PubMed ID: 12697672
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors.
Magee TR; Cai Y; El-Houseini ME; Locker J; Wan YJ
J Biol Chem; 1998 Nov; 273(45):30024-32. PubMed ID: 9792724
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional control of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4: inhibition by cyclic AMP and COUP transcription factors.
You M; Fischer M; Cho WK; Crabb D
Arch Biochem Biophys; 2002 Feb; 398(1):79-86. PubMed ID: 11811951
[TBL] [Abstract][Full Text] [Related]
9. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization.
Sladek FM; Dallas-Yang Q; Nepomuceno L
Diabetes; 1998 Jun; 47(6):985-90. PubMed ID: 9604881
[TBL] [Abstract][Full Text] [Related]
10. Differential promoter usage in prolactin receptor gene expression: hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver.
Møldrup A; Ormandy C; Nagano M; Murthy K; Banville D; Tronche F; Kelly PA
Mol Endocrinol; 1996 Jun; 10(6):661-71. PubMed ID: 8776726
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human cytochrome P4502D6 promoter. A potential role for antagonistic interactions between members of the nuclear receptor family.
Cairns W; Smith CA; McLaren AW; Wolf CR
J Biol Chem; 1996 Oct; 271(41):25269-76. PubMed ID: 8810289
[TBL] [Abstract][Full Text] [Related]
12. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels.
Shih DQ; Dansky HM; Fleisher M; Assmann G; Fajans SS; Stoffel M
Diabetes; 2000 May; 49(5):832-7. PubMed ID: 10905494
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients.
Price JA; Fossey SC; Sale MM; Brewer CS; Freedman BI; Wuerth JP; Bowden DW
Diabetologia; 2000 Mar; 43(3):364-72. PubMed ID: 10768098
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element.
Pineda Torra I; Jamshidi Y; Flavell DM; Fruchart JC; Staels B
Mol Endocrinol; 2002 May; 16(5):1013-28. PubMed ID: 11981036
[TBL] [Abstract][Full Text] [Related]
15. SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.
Wang JC; Stafford JM; Granner DK
J Biol Chem; 1998 Nov; 273(47):30847-30850. PubMed ID: 9812974
[TBL] [Abstract][Full Text] [Related]
16. HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1).
Stroup D; Chiang JY
J Lipid Res; 2000 Jan; 41(1):1-11. PubMed ID: 10627496
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree.
Lausen J; Thomas H; Lemm I; Bulman M; Borgschulze M; Lingott A; Hattersley AT; Ryffel GU
Nucleic Acids Res; 2000 Jan; 28(2):430-7. PubMed ID: 10606640
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional hierarchy in Xenopus embryogenesis: HNF4 a maternal factor involved in the developmental activation of the gene encoding the tissue specific transcription factor HNF1 alpha (LFB1).
Holewa B; Strandmann EP; Zapp D; Lorenz P; Ryffel GU
Mech Dev; 1996 Jan; 54(1):45-57. PubMed ID: 8808405
[TBL] [Abstract][Full Text] [Related]
19. Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide.
Hara H; Adachi T
Mol Pharmacol; 2002 Jan; 61(1):194-200. PubMed ID: 11752221
[TBL] [Abstract][Full Text] [Related]
20. [The study of cis-element HNF4 in the regulation of mfg12 prothrombinase/fibroleukin gene expression in response to nucleocapsid protein of MHV-3].
Ning Q; Luo XP; Wang ZM; Han MF; Yan WM; Liu MF; Levy G
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):678-83. PubMed ID: 12887828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
